(11alpha,15R)-16,16-Difluoro-15-hydroxy-9-oxo-11,15-epoxyprostan-1-oic acid(CAS: 333963-40-9)

This compound falls under the GHS classification, which requires specific hazard communication labels and safety data sheets. For production and import, it is also subject to REACH regulations in the EU, requiring detailed chemical safety assessments. In the USA, the FDA and EPA have their own specific requirements for handling, transport, and storage of such compounds.

Common alternatives in synthesis include other fluorinated prostanoids or related compounds that can serve similar biological functions. Isomers and analogs, such as (11alpha,15S)-16,16-difluoro-15-hydroxy-9-oxo-11,15-epoxyprostan-1-oic acid, may be used depending on the specific research or application needs.

This compound is currently under investigation for its potential in treating various inflammatory and neurological conditions. Market trends show increasing research interest driven by its unique structural features and pharmacological effects. However, due to its complexity, it remains a niche product with limited commercial availability.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste disposal services. Environmental protection measures include ensuring no release into the environment and following local regulations. Incineration is a common method, but appropriate temperature and control measures must be taken to prevent environmental contamination.